F
Feng Shen
Researcher at Second Military Medical University
Publications - 403
Citations - 12498
Feng Shen is an academic researcher from Second Military Medical University. The author has contributed to research in topics: Hepatocellular carcinoma & Medicine. The author has an hindex of 46, co-authored 313 publications receiving 8315 citations.
Papers
More filters
Journal ArticleDOI
Prognostic Nomogram for Intrahepatic Cholangiocarcinoma After Partial Hepatectomy
Yizhou Wang,Jun Li,Yong Xia,Renyan Gong,Kui Wang,Zhenlin Yan,Xuying Wan,Guanghua Liu,Dong Wu,Lehua Shi,Wan Yee Lau,Meng-Chao Wu,Feng Shen +12 more
TL;DR: The proposed nomogram resulted in more-accurate prognostic prediction for patients with ICC after partial hepatectomy and was superior to the five currently used staging systems on ICC.
Journal ArticleDOI
Guidelines for Diagnosis and Treatment of Primary Liver Cancer in China (2017 Edition).
Jian Zhou,Hui-Chuan Sun,Zheng Wang,Wen Ming Cong,Jian-Hua Wang,Meng Su Zeng,Jia Mei Yang,Ping Bie,Lianxin Liu,Tian Fu Wen,Guo Hong Han,Mao Qiang Wang,Rui Bao Liu,Li Gong Lu,Zheng Gang Ren,Minshan Chen,Zhao Chong Zeng,Ping Liang,Changhong Liang,Min Chen,Fu Hua Yan,Wen Ping Wang,Yuan Ji,Wen Wu Cheng,Chao Liu Dai,Wei-Dong Jia,Ya Ming Li,Ye Xiong Li,Jun Liang,Tian Shu Liu,Guo Yue Lv,Yi Lei Mao,Wei Xin Ren,Hong Cheng Shi,Wen Tao Wang,Xiaoying Wang,Bao Cai Xing,Jian Ming Xu,Jian Yong Yang,Ye Fa Yang,Sheng Long Ye,Zheng Yu Yin,Bo Heng Zhang,Shui Jun Zhang,Wei Ping Zhou,Ji Ye Zhu,Rong Liu,Ying Hong Shi,Yong Sheng Xiao,Zhi Dai,Gao Jun Teng,Jian Qiang Cai,Wei Lin Wang,Jia Hong Dong,Qiang Li,Feng Shen,Shu Kui Qin,Jia Fan +57 more
TL;DR: A guideline on the surveillance, diagnosis, staging, and treatment of HCC occurring in China is presented, and recommendations regarding patients with HCC in China are made to ensure optimum patient outcomes.
Journal ArticleDOI
Nomogram for Preoperative Estimation of Microvascular Invasion Risk in Hepatitis B Virus-Related Hepatocellular Carcinoma Within the Milan Criteria.
Zhengqing Lei,Jun Li,Dong Wu,Yong Xia,Qing Wang,Anfeng Si,Kui Wang,Xuying Wan,Wan Yee Lau,Meng-Chao Wu,Feng Shen +10 more
TL;DR: The nomogram achieved an optimal preoperative prediction of MVI in HBV-related HCC within the Milan criteria, and the risk for an individual patient to harbor MVI can be determined, which can lead to a rational therapeutic choice.
Journal ArticleDOI
Guidelines for the Diagnosis and Treatment of Hepatocellular Carcinoma (2019 Edition).
Jian Zhou,Hui-Chuan Sun,Zheng Wang,Wenming Cong,Jian-Hua Wang,Mengsu Zeng,Weiping Zhou,Ping Bie,Lianxin Liu,Tianfu Wen,Guohong Han,Maoqiang Wang,Ruibao Liu,Li Gong Lu,Zhengang Ren,Minshan Chen,Zhaochong Zeng,Ping Liang,Changhong Liang,Min Chen,Fuhua Yan,Wenping Wang,Yuan Ji,Jingping Yun,Dingfang Cai,Yongjun Chen,Wenwu Cheng,Shu-Qun Cheng,Chaoliu Dai,Wenzhi Guo,Baojin Hua,Xiaowu Huang,Wei-Dong Jia,Yaming Li,Yexiong Li,Jun Liang,Tianshu Liu,Guoyue Lv,Yilei Mao,Tao Peng,Wei Xin Ren,Hongcheng Shi,Guoming Shi,Kaishan Tao,Wentao Wang,Xiaoying Wang,Zhiming Wang,Bangde Xiang,Baocai Xing,Jian Ming Xu,Jiamei Yang,Jianyong Yang,Yefa Yang,Yunke Yang,Shenglong Ye,Zhengyu Yin,Bixiang Zhang,Boheng Zhang,Leida Zhang,Shuijun Zhang,Ti Zhang,Yongfu Zhao,Honggang Zheng,Jiye Zhu,Kangshun Zhu,Rong Liu,Yinghong Shi,Yongsheng Xiao,Zhi Dai,Gaojun Teng,Jianqiang Cai,Weilin Wang,Xiujun Cai,Qiang Li,Feng Shen,Shukui Qin,Jiahong Dong,Jia Fan +77 more
TL;DR: The new guidelines were endorsed and promulgated by the Bureau of Medical Administration of the National Health Commission of the People’s Republic of China in December 2019 and reflect the real-world situation in China regarding diagnosing and treating liver cancer in recent years.
Journal ArticleDOI
Risk Factors, Patterns, and Outcomes of Late Recurrence After Liver Resection for Hepatocellular Carcinoma: A Multicenter Study From China.
Xin-Fei Xu,Hao Xing,Jun Han,Zhen-Li Li,Wan Yee Lau,Wan Yee Lau,Ya-Hao Zhou,Wei-Min Gu,Hong Wang,Ting-Hao Chen,Yongyi Zeng,Chao Li,Meng-Chao Wu,Feng Shen,Tian Yang +14 more
TL;DR: Late recurrence after HCC resection was associated with sex, cirrhosis, and several aggressive tumor characteristics of the initial HCC, and postoperative surveillance improved the chance of potentially curative treatments, with improved survival outcomes in patients with late recurrence.